Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their most recent value-driven wins.

The 5 executives featured in this article are all speaking at the Becker’s Healthcare Fall Chief Pharmacy Officer Summit, from Nov. 5-6, 2025 at the Hilton Chicago.

To learn more about this event, click here.

If you would like to join as a reviewer, contact Mariah Muhammad at mmuhammad@beckershealthcare.com or agendateam@beckershealthcare.com.

As part of an ongoing series, Becker’s is talking to healthcare leaders who will speak at our conference. The following are answers from our speakers at the event.

Question: What are your big wins for value-driven healthcare in the last 12-18 months?

Kelley A. Curtis, PharmD. Vice President and Chief Pharmacy Officer of St. Luke’s Health System (Kansas City, Mo.): Over the past year, St. Luke’s in Idaho has advanced value-driven healthcare by aligning pharmacy strategy across the three pillars of our population health work, health plan, health network/ACO, and health system. We are hosting our inaugural Population Health Pharmacy Strategy Summit to unite leaders across these pillars and build a shared roadmap to improve affordability, access and outcomes. Key initiatives, including our GLP-1 metabolic health program, community/retail pharmacy growth, specialty pharmacy expansion, home infusion launch and home delivery services, are reducing barriers, enhancing care coordination and lowering total cost of care. These strategies are generating financial gains that can be reinvested to expand care, strengthen community outreach, and fuel future innovation. Together, these efforts highlight the power of enterprisewide integration to deliver sustainable, measurable impact for the patients and communities we serve.

Urshila Shah, PharmD. Executive Director of Pharmacy Services, Oncology Services, and Clinical Research at St. Joseph’s Health (Paterson, N.J.): Over the past 12 to 18 months, our health system has leveraged specialty pharmacy growth and 340B program optimization to drive both patient access and financial sustainability. By integrating specialty pharmacy services into our care continuum, we’ve ensured that patients — especially those with complex, high-cost conditions — receive timely medications, care coordination, and personalized adherence support. At the same time, targeted 340B strategies have generated significant savings that we reinvest directly into patient care programs and community health initiatives. This dual approach has created a measurable impact: improved clinical outcomes, reduced financial barriers for vulnerable populations, and a sustainable revenue stream that strengthens our health system’s mission.

Melanie Joe, PharmD. Chief Pharmacy Officer of UCI Health (Orange, Calif.); Associate Director and Founding Associate Dean of Pharmacy Professional Affairs at University of California, Irvine, School of Pharmacy and Pharmaceutical Sciences: At UCI Health, we achieved success with real-time access to clinical, operational, and financial data, which helps us to track patient outcomes, manage population health, and balance financial pressures while maintaining quality care to our patients. At the same time, to address workforce and operational pressures, we created promotional opportunities for technical and administrative staff to analyze and manipulate data to support initiatives as well as a mentorship program to provide emotional support and professional guidance for our team members. During this time of economic uncertainty and staffing shortages, we strive to balance cost containment with maintenance of high-quality care.

Michael Eagon, PharmD. Interim Director of Retail and Specialty Pharmacy at University of Texas Medical Branch (Galveston): Over the past several months, our pharmacy teams across ambulatory, retail, and specialty services at the University of Texas Medical Branch have made significant contributions to value-driven healthcare. In ambulatory care, we expanded pharmacist-led chronic disease management programs, improving medication adherence and reducing avoidable adverse events. Our retail pharmacy team enhanced access through streamlined refill programs and outreach, supporting preventive care efforts. Specialty pharmacy services focused on optimizing high-cost therapies and improving patient outcomes through personalized care coordination and financial assistance programs. Collectively, these initiatives have strengthened our alignment with value-based care goals and improved the patient experience across the continuum.

Darren Evans, PharmD, MPH, MHA. System Vice President of Pharmacy Services at Phoebe Putney Health System: Phoebe Putney Health System’s pharmacy team has made significant strides in value-based care over the past year. Enhanced 340B program oversight preserved savings, expanding access to affordable medications and funding vital community health programs. Specialty pharmacy services saw double-digit revenue growth while maintaining over 95% adherence for patients with complex conditions, improving both outcomes and quality of life. Phoebe also became the first health system in Georgia to secure Board of Pharmacy approval for smart locker prescription pickup. This innovation offers 24/7 access, reduces prescription abandonment, and meets patients where they are. Together, these efforts demonstrate Phoebe’s commitment to access, affordability, and patient-centered innovation.

The post The big wins defining value-driven pharmacy today appeared first on Becker’s Hospital Review | Healthcare News & Analysis.